JCJan Henk Coert

Jan Henk Coert

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jan Henk Coert has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Decompressive Surgery in Chemotherapy- and Radiotherapy- Induced Peripheral Compression Neuropathy: A Systematic Review

    by Tom Terng, Bas Schuitema, Mienke Rijsdijk, J. Henk Coert, Enrico Martin

    Background: Treatment-related peripheral neuropathies are disabling long-term complications of modern cancer therapy. Chemotherapy-induced peripheral neuropathy (CIPN) and radiation-induced peripheral neuropathy (RIPN) can lead to pain, motor deficits, and sensory loss, substantially impairing quality of life in cancer survivors. Surgical decompression has been proposed as a potential therapeutic option in cases of superimposed focal nerve compression due to treatment-related tissue changes, but evidence remains limited. This systematic review aims to evaluate the indications, surgical techniques, and outcomes of microsurgical decompression for cancer treatment-related peripheral neuropathies. Methods: A systematic search was performed in PubMed and Embase up to July 2026. Studies were screened by two independent researchers, and included when reporting outcomes of surgical intervention for chemotherapy-induced or radiation-induced peripheral neuropathy. Data on patient demographics, oncologic diagnosis, surgical indication, technique, and postoperative subjective and functional outcomes were extracted and presented in tables. Results: Fourteen studies met inclusion criteria describing 95 patients and 120 treated nerves. In CIPN, all surgically treated patients experienced pain relief and improvement in two-point discrimination, without reported deterioration. In RIPN, 88.5% of patients improved in pain, 58.8% in sensory function, and 44.4% in motor strength. Neurolysis combined with vascularized flap reconstruction was associated with better outcomes when compared with neurolysis alone. No major surgical complications were reported. Overall evidence quality was low, with small sample sizes and high heterogeneity among methodologies. Conclusions: Microsurgical decompression with or without vascularized flap reconstruction may provide meaningful pain relief and partial functional recovery in selected patients with treatment-related peripheral compression neuropathies refractory to conservative management. Nevertheless, current evidence is restricted to small retrospective series and case reports.

  • Open Access

    Acellular Normothermic Machine Perfusion Does not Exacerbate Acute Rejection in Rodent Vascularized Composite Allografts

    by Irina Filz von Reiterdank, Raphaela Bento, Eloi de Clermont-Tonnerre, Antonia T. Dinicu, Hyshem H. Lancia, Michelle E. McCarthy, Alexandre G. Lellouch, Basak E. Uygun, Curtis L. Cetrulo, J. Henk Coert, et al.

    Background.: Vascularized composite allotransplantation faces significant challenges, including limited preservation time and high rates of acute rejection because of the ischemia susceptibility of muscle and immunogenicity of skin. However, no studies have investigated whether normothermic machine perfusion (NMP) has an effect on acute rejection compared with static cold storage (SCS). Methods.: Heterotopic hindlimb transplants were performed in a full-mismatch model after 6 h of SCS or NMP. Postoperative assessments included clinical scoring, histological examination, cytokine profiling, and flow cytometry of splenocytes and lymphocytes at the end of the study. Results.: Clinical assessment revealed significantly lower rejection scores in the NMP group on postoperative day (POD) 2 ( P = 0.03). Notably, histology indicated delayed rejection, with Banff scores showing severe rejection from POD2 in the SCS group and from POD6 in the NMP group. Cytokine profiling demonstrated early upregulation of anti-inflammatory interleukin-10 in the NMP group at POD1, and flow cytometry showed a reduction in B cell populations. Conclusions.: While NMP is not a cure-all, it is associated with a delayed onset of acute rejection compared with SCS in a full-mismatch rodent vascularized composite allotransplantation model. Future studies should focus on analysis earlier in the rejection process and on long-term graft survival to further elucidate the mechanism of the effect of NMP on the immune response.

  • Open Access

    Barriers and Facilitators in Implementing the Safety Climate Thermometer: A New Tool for Surgical Teams

    by Esther Martine van der Linde, Wilhelmina M.U van Grevenstein, Alex Burdorf, J. Henk Coert, Linda S.G.L Wauben, Connie M. Dekker-Van Doorn

  • Open Access

    Differences in Diagnosing Tarsal Tunnel Syndrome Across the Literature

    by Nadine Boers, Melanie Haverkamp, Anne Merijn Eligh, Manuel Castro Cabezas, J. Henk Coert, Willem D. Rinkel

    Background: The lack of a gold standard in tarsal tunnel syndrome (TTS) diagnosis leads to diagnostic inconsistencies and variation in patient selection for treatment. Therefore, the aim of this review is to summarize the diagnostic criteria used in current studies on TTS based upon this best-evidence synthesis. Methods: Three databases were searched to identify all studies on TTS. Studies were included when they included (1) diagnosis or treatment of TTS as the primary focus, (2) a description of the diagnosis of TTS, (3) an original data set of TTS cases, and (4) a minimum of 10 adult patients diagnosed with TTS. A best-evidence synthesis was used to summarize the results. Results: In total, 4,213 patients were represented in 82 included studies. Among the varying diagnostic methods employed, aside from clinical symptoms, provocative testing was most often used (in 94% of studies, mandatory for diagnosis in 41% of studies) with the Tinel sign being the most prevalent (used in 89% of studies). Sensitivities of provocative tests, electrodiagnostic, and ultrasound measurements showed significant variability. Conclusion: We provided an overview of the diagnostic tools and workups reported in the literature on TTS. Our findings show that the lack of a standardized diagnostic approach results in considerable variability in clinical practice. Alongside typical clinical symptoms, the Tinel sign is the most frequently used diagnostic test. The varying sensitivities reported in literature underscore the need for evidence-based diagnostic guidelines on TTS diagnosis. Level of Evidence: Diagnostic Level III . See Instructions for Authors for a complete description of levels of evidence.


  • JoVE Video Dataset

    by Catherine Pommelien Marie van Den Berg, J. Henk Coert

    This protocol describes a novel surgical model to study nerve pain and surgical treatment in rats. Traditional neuroma models use mixed nerves, although it is most often the case that sensory nerves give rise to painful neuromas in the clinical setting. By selecting the saphenous nerve, this approach reflects the clinical reality of neuroma formation and provides a relevant platform for evaluating surgical strategies. This method aims to replicate the pathophysiology of human neuroma formation and to evaluate a common surgical intervention for neuroma pain, particularly targeted muscle reinnervation (TMR), a widely used intervention for neuroma-associated pain. The article provides a detailed, step-by-step description of the procedure, beginning with animal preparation and perioperative care. Surgical technique is explained with attention to anatomical landmarks, instrument requirements, and technical considerations that improve accuracy and consistency. Postoperative monitoring and welfare measures are outlined to ensure adherence to ethical standards and reproducibility across laboratories. This model is reproducible, technically accessible, and translationally relevant, as it mimics the clinical reality of sensory neuroma formation. It provides a platform for evaluating surgical strategies and preclinical neuroma research.

  • Novel Surgical Rodent Model for Studying Neuroma Pain Treatment Options using Targeted Muscle Reinnervation Through the Saphenous Nerve

    by Catherine Pommelien Marie van Den Berg, J. Henk Coert

    This protocol describes a novel surgical model to study nerve pain and surgical treatment in rats. Traditional neuroma models use mixed nerves, although it is most often the case that sensory nerves give rise to painful neuromas in the clinical setting. By selecting the saphenous nerve, this approach reflects the clinical reality of neuroma formation and provides a relevant platform for evaluating surgical strategies. This method aims to replicate the pathophysiology of human neuroma formation and to evaluate a common surgical intervention for neuroma pain, particularly targeted muscle reinnervation (TMR), a widely used intervention for neuroma-associated pain. The article provides a detailed, step-by-step description of the procedure, beginning with animal preparation and perioperative care. Surgical technique is explained with attention to anatomical landmarks, instrument requirements, and technical considerations that improve accuracy and consistency. Postoperative monitoring and welfare measures are outlined to ensure adherence to ethical standards and reproducibility across laboratories. This model is reproducible, technically accessible, and translationally relevant, as it mimics the clinical reality of sensory neuroma formation. It provides a platform for evaluating surgical strategies and preclinical neuroma research.

  • Open Access

    Breast reconstruction and neoadjuvant radiotherapy (BRENAR) – study protocol for a multicenter, prospective, single-arm pilot study

    by Sophie H. Nelissen, Danny A. Young-Afat, Joeke M. Felderhof, Patrick I. Ferdinandus, Femke van der Leij, Arjan J. Witkamp, Annemiek Doeksen, Erik H. Zonnevylle, Susanne van der Velde, Liesbeth M. Veenendaal, et al.

    Background: Over the past decade, post-mastectomy radiotherapy (PMRT) is indicated more frequently in breast cancer treatment, especially in patients with involved axillary lymph nodes. However, PMRT is associated with high complication rates and less satisfactory cosmetic results when combined with immediate breast reconstructions. This has led to ongoing controversy regarding breast reconstruction and radiotherapy, often postponing the reconstruction until long after PMRT has been completed. Preoperative radiotherapy, also known as neoadjuvant radiotherapy (NART), is emerging as a safe and promising alternative with the potential to allow immediate reconstruction without the negative effects of radiotherapy on the reconstructed breast. However, data on the complication rates and patient-reported outcomes (PROs) after NART followed by mastectomy and breast reconstruction are still limited. Methods: This is a multicenter, prospective, single-arm pilot study including breast cancer patients requiring mastectomy and PMRT, who desire immediate breast reconstruction, either implant-based or autologous. The primary objective is to assess complications three months after the last planned reconstructive surgery. The secondary objectives are to evaluate patient-reported health-related quality of life (HR-QoL), patient- and physician-reported cosmetic results, and pathological response. Discussion: The primary outcome of this pilot study is to provide further evidence to determine whether NART is a viable alternative to PMRT in terms of complication rates when combined with immediate breast reconstruction. The secondary outcomes will enhance our understanding of patients’ HR-QoL and cosmetic outcomes. If NART proves to be a safe alternative, this pilot study will lay the foundation for a national multicenter randomized controlled trial to evaluate long-term HR-QoL and oncological outcomes.


  • Open Access

    Design of the safety climate thermometer to promote team dialogue in surgical teams, using a thematic literature review and international expert panel study

    by E. M. van der Linde, L. S. G. L. Wauben, L. E. Benishek, N. E. Padmos, W. M. U. van Grevenstein, J. F. Lange, A. Burdorf, J. H. Coert, J. G. Heetman, C. M. Dekker-Van Doorn

    Introduction: A safe work climate benefits patients and healthcare professionals. Most instruments for evaluating safety climate are lengthy questionnaires focusing on either measuring and benchmarking, or identifying areas for improvement. We aimed to design a communication instrument promoting team discussion about safety in surgical teams: the safety climate thermometer (SCT). Method: First, a literature study was conducted to identify important safety themes, which were then organized into eight safety climate themes. Behavior-based assessment statements were drafted per theme. Second, an expert panel study with international experts was conducted, soliciting feedback on our initial SCT design. Their feedback led to a redesign into the SCT prototype presented in this study. Results: The literature search yielded twelve existing instruments and three reviews. Twenty-two experts participated in the panel study. The final SCT prototype framed eight safety climate themes and is organized into two parts. In Part I, team members individually and anonymously evaluate team performance per theme by responding to a single statement to quickly assess global perceptions of that theme. Based on their collective scores, the team chooses one safety climate area to investigate further by scoring one set of eight in-depth statements. In Part II, a structured interdisciplinary team discussion takes place aiming to pinpoint a work floor issue and set actionable goals for improvement. Discussion/conclusion: The SCT is a communication instrument for surgical teams that first focuses on identifying opportunities for improvement, and then structuring team discussion and follow-up, aiming to improve safety climate.


  • Open Access

    Therapeutic Efficacy of Adipose Tissue-Derived Components in Neuropathic Pain: A Systematic Review

    by Anouk A. E. Claessens, Linda Vriend, Zachri N. Ovadja, Martin C. Harmsen, Joris. A. van Dongen, J. Henk Coert

    Background: Neuropathic pain results from a defect in the somatosensory nervous system caused by a diversity of etiologies. The effect of current treat-ment with analgesics and surgery is limited. Studies report the therapeutic use of adipose tissue-derived components to treat neuropathic pain as a new treatment modality. Objective: The aim of this systematic review was to investigate the therapeutic clinical efficacy of adipose tissue-derived components on neuro-pathic pain. Methods: PubMed, Medline, Cochrane and Embase databases were searched until August 2023. Clinical studies assessing neuropathic pain after autologous fat grafting or the therapeutic use of adipose tissue-derived com-ponents were included. The outcomes of interest were neuropathic pain and quality of life. Results: In total, 433 studies were identified, of which 109 dupli-cates were removed, 324 abstracts were screened and 314 articles were excluded. In total, ten studies were included for comparison. Fat grafting and cellular stromal vascular fraction were used as treatments. Fat grafting indications were post-mastectomy pain syndrome, neuromas, post-herpetic neuropathy, neuro-pathic scar pain and trigeminal neuropathic pain. In seven studies, neuropathic pain levels decreased, and overall, quality of life did not improve. Conclusions: The therapeutic efficacy of adipose tissue-derived components in the treatment of neuropathic pain remains unclear due to the few performed clinical trials with small sample sizes for various indications. Larger and properly designed (randomized) controlled trials are required.